Methods and devices for delivery of prosthetic heart valves and other prosthetics

Description

CROSS REFERENCES TO RELATED APPLICATIONS

This application relates to U.S. patent application Ser. No. 11/066,126, entitled “Prosthetic Heart Valves, Scaffolding Structures, and Methods for Implantation of Same,” filed Feb. 25, 2005, which application is hereby incorporated by reference in its entirety. The foregoing application claims the benefit of U.S. Provisional Application Ser. No. 60/548,731, entitled “Foldable Stent for Minimally Invasive Surgery,” filed Feb. 27, 2004, and U.S. Provisional Application Ser. No. 60/559,199, entitled “Method and Multiple Balloon for Percutaneous Aortic Valve Implantation,” filed Apr. 1, 2004, each of which applications is hereby incorporated by reference in its entirety.

FIELD OF THE INVENTION

The present invention relates generally to medical devices and methods. More particularly, the present invention relates to methods and devices for delivering and deploying prosthetic heart valves and similar structures using minimally invasive surgical methods.

BACKGROUND OF THE INVENTION

Diseases and other disorders of the heart valve affect the proper flow of blood from the heart. Two categories of heart valve disease are stenosis and incompetence. Stenosis refers to a failure of the valve to open fully, due to stiffened valve tissue. Incompetence refers to valves that cause inefficient blood circulation by permitting backflow of blood in the heart.

Medication may be used to treat some heart valve disorders, but many cases require replacement of the native valve with a prosthetic heart valve. Prosthetic heart valves can be used to replace any of the native heart valves (aortic, mitral, tricuspid or pulmonary), although repair or replacement of the aortic or mitral valves is most common because they reside in the left side of the heart where pressures are the greatest. Two primary types of prosthetic heart valves are commonly used, mechanical heart valves and prosthetic tissue heart valves.

The caged ball design is one of the early mechanical heart valves. The caged ball design uses a small ball that is held in place by a welded metal cage. In the mid-1960s, another prosthetic valve was designed that used a tilting disc to better mimic the natural patterns of blood flow. The tilting-disc valves had a polymer disc held in place by two welded struts. The bileaflet valve was introduced in the late 1970s. It included two semicircular leaflets that pivot on hinges. The leaflets swing open completely, parallel to the direction of the blood flow. They do not close completely, which allows some backflow.

The main advantages of mechanical valves are their high durability. Mechanical heart valves are placed in young patients because they typically last for the lifetime of the patient. The main problem with all mechanical valves is the increased risk of blood clotting.

Prosthetic tissue valves include human tissue valves and animal tissue valves. Both types are often referred to as bioprosthetic valves. The design of bioprosthetic valves are closer to the design of the natural valve. Bioprosthetic valves do not require long-term anticoagulants, have better hemodynamics, do not cause damage to blood cells, and do not suffer from many of the structural problems experienced by the mechanical heart valves.

Human tissue valves include homografts, which are valves that are transplanted from another human being, and autografts, which are valves that are transplanted from one position to another within the same person.

Animal tissue valves are most often heart tissues recovered from animals. The recovered tissues are typically stiffened by a tanning solution, most often glutaraldehyde. The most commonly used animal tissues are porcine, bovine, and equine pericardial tissue.

The animal tissue valves are typically stented valves. Stentless valves are made by removing the entire aortic root and adjacent aorta as a block, usually from a pig. The coronary arteries are tied off, and the entire section is trimmed and then implanted into the patient.

A conventional heart valve replacement surgery involves accessing the heart in the patent's thoracic cavity through a longitudinal incision in the chest. For example, a median sternotomy requires cutting through the sternum and forcing the two opposing halves of the rib cage to be spread apart, allowing access to the thoracic cavity and heart within. The patient is then placed on cardiopulmonary bypass which involves stopping the heart to permit access to the internal chambers. Such open heart surgery is particularly invasive and involves a lengthy and difficult recovery period.

A less invasive approach to valve replacement is desired. The percutaneous implantation of a prosthetic valve is a preferred procedure because the operation is performed under local anesthesia, does not require cardiopulmonary bypass, and is less traumatic. Current attempts to provide such a device generally involve stent-like structures, which are very similar to those used in vascular stent procedures with the exception of being larger diameter as required for the aortic anatomy, as well as having leaflets attached to provide one way blood flow. These stent structures are radially contracted for delivery to the intended site, and then expanded/deployed to achieve a tubular structure in the annulus. The stent structure needs to provide two primary functions. First, the structure needs to provide adequate radial stiffness when in the expanded state. Radial stiffness is required to maintain the cylindrical shape of the structure, which assures the leaflets coapt properly. Proper leaflet coaption assures the edges of the leaflets mate properly, which is necessary for proper sealing without leaks. Radial stiffness also assures that there will be no paravalvular leakage, which is leaking between the valve and aorta interface, rather than through the leaflets. An additional need for radial stiffness is to provide sufficient interaction between the valve and native aortic wall that there will be no valve migration as the valve closes and holds full body blood pressure. This is a requirement that other vascular devices are not subjected to. The second primary function of the stent structure is the ability to be crimped to a reduced size for implantation.

Prior devices have utilized traditional stenting designs which are produced from tubing or wire wound structures. Although this type of design can provide for crimpability, it provides little radial stiffness. These devices are subject to “radial recoil” in that when the device is deployed, typically with balloon expansion, the final deployed diameter is smaller than the diameter the balloon and stent structure were expanded to. The recoil is due in part because of the stiffness mismatches between the device and the anatomical environment in which it is placed. These devices also commonly cause crushing, tearing, or other deformation to the valve leaflets during the contraction and expansion procedures. Other stenting designs have included spirally wound metallic sheets. This type of design provides high radial stiffness, yet crimping results in large material strains that can cause stress fractures and extremely large amounts of stored energy in the constrained state. Replacement heart valves are expected to survive for many years when implanted. A heart valve sees approximately 500,000,000 cycles over the course of 15 years. High stress states during crimping can reduce the fatigue life of the device. Still other devices have included tubing, wire wound structures, or spirally wound sheets formed of nitinol or other superelastic or shape memory material. These devices suffer from some of the same deficiencies as those described above.

A number of improved prosthetic heart valves and scaffolding structures are described in co-pending U.S. patent application Ser. No. 11/066,126, entitled “Prosthetic Heart Valves, Scaffolding Structures, and Methods for Implantation of Same,” filed Feb. 25, 2005, (“the '126 application”) which application is hereby incorporated by reference in its entirety. Several of the prosthetic heart valves described in the '126 application include a support member having a valvular body attached, the support member preferably comprising a structure having three panels separated by three foldable junctions. The '126 application also describes several delivery mechanisms adapted to deliver the described prosthetic heart valve. Although the prosthetic heart valves and delivery systems described in the '126 application represent a substantial advance in the art, additional delivery systems and methods are desired, particularly such systems and methods that are adapted to deliver and deploy the prosthetic heart valves described therein.

SUMMARY OF THE INVENTION

The present invention provides methods and devices for deploying prosthetic heart valves and other prosthetic devices in body lumens. The methods and devices are particularly adapted for use in percutaneous aortic valve replacement. The methods and devices may also find use in the peripheral vasculature, the abdominal vasculature, and in other ducts such as the biliary duct, the fallopian tubes, and similar lumen structures within the body of a patient. Although particularly adapted for use in lumens found in the human body, the apparatus and methods may also find application in the treatment of animals.

Without intending to limit the scope of the methods and devices described herein, the deployment devices and methods are particularly adapted for delivery of prosthetic heart valves and scaffolding structures identical or similar to those described in the '126 application described above. A particularly preferred prosthetic heart valve includes a generally cylindrical support structure formed of three segments, such as panels, interconnected by three foldable junctions, such as hinges, a representative embodiment of which is illustrated in FIG. 1A of the '126 application, which is reproduced herein as FIG. 1A. The exemplary prosthetic valve 30 includes a generally cylindrical support member 32 made up of three generally identical curved panels 36 and a valvular body 34 attached to the internal surface of the support member. Each panel includes an aperture 40 through which extends a plurality of interconnecting braces 42 that define a number of sub-apertures 44, 46, 48, 50. A hinge 52 is formed at the junction formed between each pair of adjacent panels. The hinge may be a membrane hinge comprising a thin sheet of elastomeric material 54 attached to the external edge 56 of each of a pair of adjacent panels 36.

Turning to FIG. 1B-C, a method for transforming a prosthetic valve from its expanded state to its contracted state is illustrated. These Figures show a three-panel support member without a valvular body attached. The method for contracting a full prosthetic valve, including the attached valvular body, is similar to that described herein in relation to the support member alone. As shown in FIG. 1B, each of the panels 36 is first inverted, by which is meant that a longitudinal centerline 80 of each of the panels 36 is forced radially inward toward the central longitudinal axis 82 of the support member. This action is facilitated by having panels formed of a thin, resilient sheet of material having generally elastic properties, and by the presence of the hinges 52 located at the junction between each pair of adjacent panels 36. During the inversion step, the edges 56 of each of the adjacent pairs of panels fold upon one another at the hinge 52. The resulting structure, shown in FIG. 1B, is a three-vertex 58 star shaped structure, referred to herein as a “tri-star” shape. Those skilled in the art will recognize that a similar procedure may be used to invert a four (or more) panel support member, in which case the resulting structure would be a four (or more) vertex star shaped structure.

The prosthetic valve 30 may be further contracted by curling each of the vertices 58 of the star shaped structure to form a multi-lobe structure, as shown in FIG. 1C. As shown in that Figure, each of the three vertices 58 is rotated toward the center longitudinal axis 82 of the device, causing each of the three folded-upon edges of the adjacent pairs of panels to curl into a lobe 84. The resulting structure, illustrated in FIG. 1C, is a “tri-lobe” structure that represents the fully contracted state of the prosthetic valve. Those skilled in the art will recognize that a similar procedure may be used to fully contract a four (or more) panel support member, in which case the resulting structure would be a four (or more) lobed structure.

The foregoing processes are performed in reverse to transform the prosthetic valve from its contracted state to its expanded state. For example, beginning with the prosthetic valve in its “tri-lobe” position shown in FIG. 1C, the three vertices 58 may be extended radially to achieve the “tri-star” shape shown in FIG. 1B. The “tri-star” shape shown in FIG. 1B is typically not stable, as the panels 36 tend to spontaneously expand from the inverted shape to the fully expanded shape shown in FIG. 1A unless the panels are otherwise constrained. Alternatively, if the panels do not spontaneously transition to the expanded state, it will typically only require a slight amount of force over a relatively short amount of distance in order to cause the panels to fully expand. For example, because of the geometry of the three panel structure, a structure having an expanded diameter of about 21 mm would be fully expanded by insertion of an expanding member having a diameter of only 16 mm into the interior of the structure. In such a circumstance, the 16 mm diameter member would contact the centerline of each panel and provide sufficient force to cause each panel to transform from the inverted shape shown in FIG. 1B to the fully expanded shape shown in FIG. 1A. This is in contrast to a typical “stent”-like support structure, which requires an expanding member to expand the stent to its full radial distance.

Additional details of this and other embodiments of the prosthetic heart valve and scaffolding structures are provided in the '126 application, to which the present description refers. It is to be understood that those prosthetic heart valves and scaffolding structures are only examples of such valves and prosthetic devices that are suitable for use with the devices and methods described herein. For example, the present devices and methods are suitable for delivering valves and prosthetic devices having any cross-sectional or longitudinal profile, and is not limited to those valves and devices described in the '126 application or elsewhere.

Turning to the deployment devices and methods, in one aspect of the present invention, a delivery catheter for prosthetic heart valves and other devices is provided. The delivery catheter is preferably adapted for use with a conventional guidewire, having an internal longitudinal lumen for passage of the guidewire. The delivery catheter includes a handle portion located at a proximal end of the catheter, a deployment mechanism located at the distal end of the catheter, and a catheter shaft interposed between and operatively interconnecting the handle portion and the deployment mechanism. The deployment mechanism includes several components that provide the delivery catheter with the ability to receive and retain a prosthetic valve or other device in a contracted, delivery state, to convert the prosthetic device to a partially expanded state, and then to release the prosthetic valve completely from the delivery device. In several preferred embodiments, the deployment mechanism includes an outer slotted tube, a plurality of wrapping pins attached to a hub and located on the interior of the slotted tube, and a plurality of restraining members that extend through the wrapping pins to the distal end of the catheter. Each of the deployment mechanism components is individually controlled by a corresponding mechanism carried on the handle portion of the catheter. The deployment mechanism preferably also includes a nosecone having an atraumatic distal end.

In several particularly preferred embodiments, the restraining members comprise tethers in the form of a wire, a cable, or other long, thin member made up of one or more of a metal such as stainless steel, metallic alloys, polymeric materials, or other suitable materials. A particularly preferred form of the tethers is suture material. In several embodiments, the tethers are adapted to engage the guidewire that extends distally past the distal end of the delivery catheter. The tethers preferably engage the guidewire by having a loop, an eyelet, or other similar construction at the distal end of the tether. Optionally, the tether is simply looped around the guidewire and doubles back to the catheter handle. Thus, the tethers are released when the guidewire is retracted proximally into the delivery catheter. In still other embodiments, the tethers may be released from the guidewire by actuation of a member carried on the handle mechanism at the proximal end of the catheter. In still other embodiments, a post or tab is provided on the guidewire, and the tether engages the post or tab but is able to bend or break free from the post or tab when a proximally-oriented force is applied to the tethers.

In a second aspect of the present invention, several optional active deployment mechanisms are described. The active deployment mechanisms are intended to convert a prosthetic valve, scaffolding structure, or similar device from an undeployed, partially deployed, or not-fully deployed state to its fully expanded state. Several of the active deployment mechanisms take advantage of the fact that the preferred prosthetic valves and scaffolding structures require only a small amount of force applied any any of a large number of points or locations on the valve or structure in order to cause the valve to fully expand. Exemplary embodiments of the active deployment mechanisms include embodiments utilizing expandable members that are placed into the interior of the prosthetic valve and then expanded; embodiments that operate by causing the hinges of the undeployed prosthetic valve to open, thereby transitioning to the fully expanded state; embodiments that include implements that engage one or more of the panels to cause the panel to expand to its deployed state; and other embodiments described herein.

Other aspects, features, and functions of the inventions described herein will become apparent by reference to the drawings and the detailed description of the preferred embodiments set forth below.

DESCRIPTION OF THE DRAWINGS

FIG. 1A is a perspective view of a prosthetic valve suitable for use by the delivery catheter of the present invention.

FIG. 1B is a top view of a partially contracted support member illustrating inverted panels to form a “tri-star” shape.

FIG. 1C is a top view of a fully contracted support member illustrating inverted and curled panels to form a “tri-lobe” shape.

FIG. 2 is a perspective view of a delivery catheter in accordance with the present invention.

FIG. 3 is a perspective view of a deployment mechanism of the delivery catheter of FIG. 2.

FIG. 3A is a cross-sectional view of the deployment mechanism shown in FIG. 3.

FIG. 3B is a perspective view of several of the internal components included in the deployment mechanism shown in FIG. 3.

FIG. 3C is a perspective view of a wrapping pin stabilizer.

FIGS. 3D-F are cross-sectional views of wrapping pins and their associated tethers.

FIG. 3G is another perspective view of a wrapping pin stabilizer.

FIG. 4 is a perspective view of a handle mechanism of the delivery catheter shown in FIG. 2.

FIG. 5 is a cross-sectional view of the handle mechanism shown in FIG. 4.

FIG. 6 is a side view of the handle mechanism of the delivery catheter shown in FIG. 2, illustrating several positions corresponding with steps performed during use of the delivery catheter to deliver a prosthetic device.

FIG. 7 is a perspective view of the deployment mechanism, shown with a prosthetic valve in a star shape and with the slotted tube fully advanced.

FIG. 8 is a perspective view of the deployment mechanism, shown with a prosthetic valve in a star shape with the wrapping pins fully advanced and with the slotted tube retracted.

FIG. 9 is a perspective view of the deployment mechanism, shown with a prosthetic valve in a star shape with the wrapping pins and the slotted tube retracted.

FIG. 9A is a closeup view of the nosecone and guidewire shown in FIG. 9, showing detail of the manner in which a tether is looped over the guidewire.

FIG. 10 is a perspective view of the deployment mechanism, shown with a prosthetic valve in expanded shape with tethers retaining the valve in place.

FIG. 11 is a perspective view of the deployment mechanism, shown with a prosthetic valve in expanded shape, and showing the guidewire and tethers withdrawn to release the valve.

FIGS. 12A-B are side cross-sectional and end views, respectively, of a portion of the distal end of a delivery catheter, illustrating an eyelet formed on the ends of each tether.

FIGS. 12C-D are side cross-sectional views of a first wrapping pin having no recess, and a second wrapping pin having an eyelet recess formed therein.

FIG. 12E is an end cross-sectional view of a prosthetic valve partially restrained by three dual tethers.

FIGS. 12F-G are illustrations of two methods for selectively attaching dual tethers to a guidewire.

FIG. 13 is a side view of a portion of a delivery catheter illustrating a valve stop formed on each tether.

FIGS. 14A-B are side partial cross-sectional views of a portion of a delivery catheter illustrating tethers including linkage members. FIG. 14A shows a valve in its expanded state, and FIG. 14B shows the valve in its “tri-star” state.

FIG. 15 is a side view in partial cross-section of a delivery catheter illustrating tethers having loops that are routed through throughholes in the nosecone.

FIGS. 16A-B are a side view in partial cross-section and an end view showing a slotted nosecone.

FIG. 17 is a side view in partial cross-section of a delivery catheter illustrating tethers having primary and secondary sections.

FIGS. 18A-B are side views of a portion of a prosthetic valve having loops for engaging a tether to prevent migration.

FIGS. 19A-D are side views of several embodiments of wrapping pins.

FIGS. 20A-B are side views in partial cross-section showing a pair (out of three) of articulating wrapping pins, forming a gripper mechanism.

FIGS. 21A-B are an end perspective view in partial cross-section and a top view in partial cross-section of a slotted tube.

FIG. 21C is a side cross-sectional view of a slotted tube having runners and a valve panel in its contracted state.

FIGS. 22A-B are a perspective view and an end view, respectively, of an alternative deployment mechanism for a delivery catheter.

FIG. 23A is an illustration of a shape set nosecone shaft.

FIG. 23B is a cross-sectional end view of the shape set nosecone shaft of FIG. 23A.

FIG. 23C is a side view of the shape set nosecone shaft of FIG. 23A showing the tensioning member in tension.

FIGS. 24A-C illustrate a side view in partial cross-section and two end views, respectively, of an active deployment mechanism for deploying a valve, in accordance with the present invention.

FIGS. 25A-C illustrate side views in partial cross-section of another active deployment mechanism for deploying a valve, in accordance with the present invention.

FIGS. 26A-E illustrate several embodiments of active deployment mechanism employing inflatable members, such as balloons.

FIGS. 27A-B illustrates another embodiment of an active deployment mechanism employing inflatable members, such as balloons.

FIG. 28 illustrates an active deployment mechanism utilizing a roller and pincher.

FIGS. 29A-B illustrate an active deployment mechanism utilizing a wedge.

FIG. 30 illustrates an active deployment mechanism utilizing a torsion spring.

FIGS. 31A-B illustrate an active deployment mechanism utilizing a membrane balloon mounted on a slotted tube.

FIG. 32 illustrates an active deployment mechanism utilizing a plurality of linkages able to be expanded by an inflatable member.

FIGS. 33A-B illustrate an active deployment mechanism utilizing an expansion balloon mounted within the nosecone of a delivery catheter.

FIGS. 34A-C illustrate an active deployment mechanism utilizing a yoke and linkage system adapted to extend radially outward upon actuation.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Before the present invention is described, it is to be understood that this invention is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.

Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which these inventions belong. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present invention, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.

It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.

The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.

As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present inventions.

A. Delivery Devices and Methods of Use

Devices for delivering prosthetic valves and other devices to a treatment location in a body lumen are described below, as are methods for their use. The delivery devices are particularly adapted for use in minimally invasive interventional procedures, such as percutaneous aortic valve replacements. FIG. 2 illustrates a preferred embodiment of the device, in the form of a delivery catheter. The delivery catheter 100 includes a handle mechanism 102 located at the proximal end of the catheter, a deployment mechanism 104 located at the distal end of the device, and a shaft 106 extending between and interconnecting the handle mechanism 102 and the deployment mechanism 104. The catheter 100 is preferably provided with a guidewire lumen extending through the entire length of the catheter, such that a guidewire 108 is able to extend through the delivery catheter in an “over-the-wire” construction. In an optional embodiment (not shown in the drawings), the catheter 100 is provided with a “rapid-exchange” construction whereby the guidewire exits the catheter shaft through an exit port located near the distal end of the catheter. The cross-sectional profile of the deployment mechanism 104 and the shaft 106 are of a sufficiently small size that they are able to be advanced within the vasculature of a patient to a target location, such as the valve root of one or more of the valves of the heart. A preferred route of entry is through the femoral artery in a manner known to those skilled in the art. Thus, the deployment mechanism 104 has a preferred maximum diameter of approximately 24 Fr. It is understood, however, that the maximum and minimum transverse dimensions of the deployment mechanism 104 may be varied in order to obtain necessary or desired results.

The deployment mechanism 104 is provided with components, structures, and/or features that provide the delivery catheter with the ability to retain a prosthetic valve (or other prosthetic device) in a contracted state, to deliver the valve to a treatment location, to convert the prosthetic valve to its deployed state (or to allow the valve to convert to its deployed state on its own), to retain control over the valve to make any necessary final position adjustments, and to convert the prosthetic valve to its contracted state and withdraw the valve (if needed). These components, structures, and/or features of the preferred deployment mechanism are described below.

Turning to FIGS. 3 and 3A, the deployment mechanism 104 is shown in its fully contracted state for use when the mechanism 104 has not yet reached the target site within the body of a patient, such as prior to use and during the delivery process. The deployment mechanism 104 includes a slotted tube 110 that is connected to an outer sheath 112 of the catheter shaft 106, such as by way of the attachment collar 111 (shown in FIG. 3A). Thus, longitudinal movement or rotation of the outer sheath 112 causes longitudinal movement or rotation of the slotted tube 110. The slotted tube 110 is a generally cylindrical body that includes a plurality of longitudinal slots 114 that extend from the distal end of the slotted tube 110 to near its proximal end. In the preferred delivery catheter, the slotted tube 110 includes three slots 114 spaced equidistantly about the circumference of the slotted tube 110. The slots 114 have a length and width that are sufficient to accommodate the extension of portions of the prosthetic valve 30 therethrough, as described more fully below in reference to FIG. 7, described elsewhere herein. The slotted tube 110 is preferably formed of stainless steel or other generally rigid material suitable for use in medical devices or similar applications.

The deployment mechanism 104 may also include a retainer ring 116 and a nosecone 118. Although the retainer ring 116 and nosecone 118 are not necessary parts of the delivery catheter, each of these components may provide additional features and functionality when present. The nosecone 118 is located at the distal end of the delivery catheter and is preferably provided with a generally blunt, atraumatic tip 120 to facilitate passage of the catheter through the patient's vasculature while minimizing damage to the vessel walls. The nosecone 118 is preferably formed of any suitable biocompatible material. In several preferred embodiments, the nosecone is formed of a relatively soft elastomeric material, such as a polyurethane, a polyester, or other polymeric or silicone-based material. In other embodiments, the nosecone is formed of a more rigid material, such as a plastic, a metal, or a metal alloy material. The nosecone may be coated with a coating material or coating layer to provide advantageous properties, such as reduced friction or increased protection against damage. It is also advantageous to provide the nosecone with an atraumatic shape, at least at its distal end, or to form the nosecone 118 of materials that will provide the atraumatic properties while still providing structural integrity to the distal end of the device. The nosecone 118 preferably includes a plurality of throughholes 122 that extend through the length of the nosecone to allow passage of a plurality of tethers 124, which are described more fully below. A pair of slots 119 are formed on the exterior of the nosecone 118. The slots 119 provide a pair of surfaces for a wrench or other tool to grasp the nosecone 118 to enable manual manipulation of the nosecone 118, for purposes to be described below.

The retainer ring 116 is a generally cylindrically shaped ring that is located generally between the slotted tube 110 and the nosecone 118. More precisely, when the deployment mechanism 104 is in the fully contracted state shown in FIGS. 3 and 3A, the retainer ring 116 preferably overlaps a ledge 126 formed on the distal end of the slotted tube 110. Alternatively, the inner diameter of the retainer ring 116 may be formed slightly larger than the outer diameter of the slotted tube 110, thereby allowing the distal ends of the slotted tube 110 to slide within the retainer ring 116 without the need for a ledge 126. In this way, the retainer ring 116 prevents the distal ends of the slotted tube 110 from bowing outward due to pressure caused by the prosthetic valve being stored within the deployment mechanism 104.

The proximal end of the retainer ring 116 engages a bearing 128 that is formed integrally with the nosecone 118, and that allows the nosecone 118 to rotate inside and independently from the retainer ring 116. As described below, the slotted tube 110 is rotated relative to the nosecone shaft 136 and the wrapping pins 130 during some operations of the deployment mechanism, primarily during the expansion and contraction of the prosthetic valve. Without the bearing 128 (or a suitable alternative), the prosthetic valve would tend to bind up within the deployment mechanism and prevent relative rotation between the slotted tube 110 and the wrapping pins 130. Thus, the provision of the bearing 128 engaged with the retainer ring 116 facilitates this rotation of the slotted tube 110, which engages the retainer ring 116.

Additional features of the interior of the deployment mechanism are illustrated in the cross-sectional view shown in FIGS. 3A-G. A plurality of fixed wrapping pins 130 are attached to a wrapping pin hub 132 and extend longitudinally from the hub 132 toward the distal end of the catheter. The preferred embodiment of the delivery catheter includes three wrapping pins 130, although more or fewer are possible. The hub 132 is attached to a wrapping pin shaft 134 that extends proximally from the hub 132 beneath the outer sheath 112 of the catheter shaft 106. Thus, movement or rotation of the wrapping pin shaft 134 causes longitudinal movement or rotation of the hub 132 and the three wrapping pins 130. A wrapping pin stabilizer 133 is slidably attached to the outer surfaces of each of the wrapping pins 130. The pin stabilizer 133 is a generally disc-shaped member having a center hole 133a and three equally spaced throughholes 133b to accommodate the three wrapping pins 130. As described below, in certain orientations of the deployment mechanism 104, the pin stabilizer 133 provides support and stability to the wrapping pins 130 extending distally from the wrapping pin hub 132.

Turning to FIGS. 3D-F, in several of the preferred embodiments, the tethers 124 extend through or are otherwise engaged with the wrapping pins 130. The Figures illustrate several methods by which this is done. In the closed configuration, shown in FIG. 3D, the wrapping pin 130 includes a central lumen 131a through which the tether 124 extends. The lumen 131a extends through the length of the wrapping pin 130 and through the hub 132, allowing the tether to extend proximally to the handle mechanism 102. In the open configuration, shown in FIG. 3E, the wrapping pin 130 includes a channel 131b formed on its underside. The tether 124 is able to be received in the channel 131b, although it is not necessarily retained therein. In the guided configuration, shown in FIG. 3F, the wrapping pin 130 includes a channel 131b formed on its underside. A tether guide 135 is located in the channel 131b, and is preferably attached to the handle housing 152 by welding, adhesive, or other suitable method. The tether 124 is routed through the guide 135, and is thereby retained within the guide 135.

A nosecone shaft 136 is located internally of the wrapping pin shaft 134. The nosecone 118 is attached to the nosecone shaft 136, and the nosecone shaft 136 is slidably received through the wrapping pin hub 132. However, the nosecone shaft 136 is fixed to the wrapping pin stabilizer 133. Thus, longitudinal movement of the nosecone shaft 136 causes longitudinal movement of the nosecone 118 and the pin stabilizer 133, independent of any of the other components of the deployment mechanism 104. However, rotation of the handle housing 152 causes rotation of the nosecone 118, the pin stabilizer 133, and the wrapping pins 130. The nosecone shaft 136 is hollow, thereby defining a guidewire lumen 137 through its center.

A plurality of wrapping pin sockets 138 are formed on the proximal side of the nosecone 118. Each socket 138 is generally cylindrical and has a size adapted to receive the distal portion of a wrapping pin 130 therein. When the distal ends of the wrapping pins 130 are engaged with their respective sockets 138, the sockets 138 provide support and rigidity to the wrapping pins 130. This support and rigidity is particularly needed during the wrapping and unwrapping of the prosthetic valve, as described more fully below. During those operations, a large amount of strain is imparted to each of the wrapping pins 130, which strain is absorbed in part by the sockets 138 formed in the nosecone 118. Each socket 138 is also provided with a hole 140 that provides access to a respective throughhole 122 in the nosecone 118. As described more fully below, this provides a passage for a tether 124 that is contained within each wrapping pin 130 to extend through the hole 140 in each socket, through the throughhole 122 to the distal end of the nosecone 118.

Although it is not shown in the cross-sectional view in FIG. 3A, a prosthetic valve 30 such as the type described herein in relation to FIGS. 1A-C—and in the '126 application—may be retained on the wrapping pins 130 in the interior of the slotted tube 110. A suitable method for loading the valve 30 into the device will be described below. The valve 30 is retained in a contracted, multi-lobe state (see, e.g., FIG. 1C) in which each “lobe” is generally wrapped around a respective wrapping pin 130, and held in place there by engagement with the interior surface of the slotted tube 110.

Turning now to FIGS. 4-6, the handle mechanism 102 will be described. The handle mechanism 102 includes a slotted tube grip 150 that is fixedly connected to the outer sheath 112 while being slidably and rotatably mounted on a handle housing 152. The handle housing 152 is a generally cylindrical hollow shaft. The slotted tube grip 150 is preferably formed of or covered with a corrugated polymer or rubber material to provide the ability to easily grasp and manipulate the grip 150. Similarly, a wrapping pin grip 154, also preferably formed of or covered with a corrugated polymer or rubber material, is slidably mounted to the handle housing 152. The wrapping pin grip 154 includes a bolt 156 that extends through a slot 158 formed in the handle housing 152, to engage the proximal end of the wrapping pin shaft 134. A tether grip 160 is slidably mounted over the proximal end of the handle housing 152. The tether grip 160 is also generally cylindrical, having a slightly larger diameter than the handle housing 152, thereby allowing the tether grip 160 to slide over the handle housing 152 in a telescoping manner. A locking screw 162 extends through a slot 164 formed in the tether grip 160 and into the side of the handle housing 152 near its proximal end. The locking screw 162 allows the user to fix the position of the tether grip 160 relative to the handle housing 152 by screwing the locking screw 162 down.

Three tether clamps 166 extend from the proximal end of the tether grip 160. Each tether clamp 166 is independently clamped to a tether 124 that extends through the catheter to its distal end, as explained in more detail herein. Each tether clamp 166 also includes a spring mechanism (not shown) that provides independent tensioning for each tether 124. The proximal end of the nosecone shaft 136 extends out of the proximal end of the tether grip 160, between the three tether clamps 166, terminating in a small cylindrical nosecone shaft grip 168. The guidewire 108 is shown extending out of the proximal end of the nosecone shaft 136.

The preferred embodiment of the valve delivery catheter so described is intended to be used to deliver and deploy a prosthetic device, such as a prosthetic heart valve, to a patient using minimally invasive surgical techniques. Turning to FIGS. 6-11, a representative method of use of the device will be described. The device is intended to be introduced to the vasculature of a patient over a standard guidewire that has been previously introduced by any known technique, with access via the femoral artery being the preferred method. The guidewire is advanced to the treatment location under x-ray or other guidance, such as to the root of a heart valve, such as the aortic valve. Once the guidewire is in place, the valve delivery catheter 100 is advanced over the guidewire until the deployment mechanism 104 reaches the treatment location. During the delivery process, the deployment mechanism is in the fully contracted state shown, for example, in FIGS. 2 and 3.

Once the deployment mechanism 104 is located near the treatment location, the valve deployment process begins. The guidewire 108 is initially left in place through the deployment process, and is not withdrawn until a particular point in the process defined below. The valve deployment process includes manipulation of the slotted tube grip 150, wrapping pin grip 154, and tether grip 160 located on the handle mechanism 102, which cause a series of manipulations of the slotted tube 110, wrapping pin hub 132 and wrapping pins 130, and the tethers 124, in order to release and deploy the prosthetic valve in a manner that provides control during deployment and the ability to precisely position, re-position, and (if necessary) retrieve the prosthetic valve at any time during the deployment process. FIG. 6 illustrates several of the positions of the components of the handle mechanism 102 during the preferred deployment process. These positions correspond to several of the delivery steps illustrated in FIGS. 7-11.

As noted elsewhere herein, it is possible to provide valves that are contracted into other sizes and orientations (such as two lobes or four or more lobes), which would also include a delivery catheter having a different number of slots in the slotted tube 110 and a different number of wrapping pins 130. For clarity, the present description will focus entirely upon the valve 30 having three panels 36 and three hinges 52, and a delivery catheter 100 having three slots 114 in the slotted tube 110 and three wrapping pins 130.

Turning to FIGS. 6 and 7, the first step in deploying the prosthetic valve 30 is to partially expand the contracted valve from the “tri-lobe” shape (see FIG. 1C) to the “tri-star” shape (see FIG. 1B). This is done by causing relative rotation between the slotted tube 110 and the wrapping pins 130. As shown in FIG. 6, this is done by rotating the slotted tube grip 150 around the longitudinal axis of the delivery catheter, thereby causing the slotted tube 110 to rotate around the wrapping pins 130, which are maintained stationary. This relative rotation is facilitated by the provision of the bearing 128 in the nosecone 118 of the deployment mechanism 104, as illustrated in FIG. 3A. As the slotted tube 110 rotates relative to the wrapping pins 130, each of the vertices 58 of the prosthetic valve 30 is caused to extend outward through its respective slot 114 in the slotted tube 110. Rotation of the slotted tube grip 150 is stopped when the valve 30 achieves the “tri-star” shape shown in FIG. 7. At all times during the process up to this point, the adjustable components on the handle mechanism (i.e., the tether grip 160, the wrapping pin grip 154, and the slotted tube grip 150) are maintained in position “a”, wherein the tether grip 160 is in its fully retracted position, and the wrapping pin grip 154 and slotted tube grip 150 are each in their fully advanced positions.

Turning next to FIGS. 6 and 8, the next step in the deployment process is to retract the slotted tube 110 to further expose the prosthetic valve 30. This is done by retracting the slotted tube grip 150 to position “b” (FIG. 6) while maintaining the wrapping pin grip 154 and tether grip 160 in the same position “b”. Retracting the slotted tube 110 causes the valve 30 to become more exposed, but the valve 30 is maintained in the “tri-star” shape by the wrapping pins 130 which continue to engage each of the three panels 36 of the valve 30. Although not shown in FIG. 8, the distal ends of the wrapping pins 130 also remain seated in the wrapping pin sockets 138 located in the proximal-facing portion of the nosecone 118. In this “b” position, the wrapping pin stabilizer 133 is located just proximally of the valve 30 and is just distal of the wrapping pin hub 132.

Next, turning to FIGS. 6 and 9, the wrapping pins 130 are retracted by retracting the wrapping pin grip 154 to position “c” (as shown in the Figure, transitioning from position “b” to position “c” requires no adjustment of either the slotted tube grip 150 or the tether grip 160). Retracting the wrapping pins 130 causes the wrapping pins 130 to become disengaged from the valve 30 and to retract to the interior of the slotted tube 110. The wrapping pin stabilizer 133, which is fixed to the nosecone shaft 136, slides along the length of the wrapping pins 130 until maximum retraction of the wrapping pins 130, which corresponds to the position shown in FIG. 9, with the stabilizer 133 near the distal ends of each of the wrapping pins 130. In this position, the stabilizer 133 provides support and rigidity to the nosecone shaft 136, which is otherwise only supported by the wrapping pin hub 132. As shown, for example, in FIG. 9, the stabilizer 133 effectively decreases the cantilever length of the nosecone shaft 136, thereby providing it with increased stability. The stabilizer 133 also serves as a backing member for the prosthetic valve 30, preventing the valve 30 from moving proximally as the wrapping pins 130 are retracted. Further, the stabilizer 133 also serves as a guide for the tethers 124 as they extend from the distal ends of the wrapping pins 130.

The valve remains in the “tri-star” position due to the presence of the tethers 124, the spacing of which is maintained by the holes in the stabilizer 133 through which the wrapping pins 130 and tethers 124 extend. In the preferred embodiment shown in FIGS. 9 and 9A, a tether 124 extends through each of the wrapping pins 130, through the hole 140 in the socket 138, through the throughholes 122 in the nosecone 118, and is looped around the guidewire 108 on the distal side of the nosecone 118. The tethers 124 each extend proximally through and within the catheter shaft 106 and is received and retained in its respective tether clamp 166 near the proximal end of the catheter 100. In the position shown in FIG. 9, the tethers 124 are all maintained sufficiently taut that they retain the valve 30 in the “tri-star” orientation shown in the Figure. This corresponds with position “c” of the tether grip 160 relative to the handle housing 152, shown in FIG. 6.

In an alternative embodiment, the tethers 124 may be tensioned by manipulation of the distal connection of the tethers 124 to the guidewire 108. For example, rotation of the nosecone shaft 136 will cause the tethers 124 to wrap around the guidewire 108, thereby providing tension to the tethers 124. Other suitable methods for tensioning the tethers 124 are also contemplated, as will be understood by those skilled in the art.

Turning next to FIGS. 6 and 10, expansion of the valve 30 is obtained by loosening the tethers 124 that otherwise hold the valve 30 in the “tri-star” position. This transition is achieved by advancing the tether grip 160 to position “d”, as shown in FIG. 6. (Note: Transitioning from position “c” to position “d” requires no adjustment of either the slotted tube grip 150 or the wrapping pin grip 154). Advancement of the tether grip 160 relative to the handle housing 152 creates slack in the tethers 124, which slack is taken up by the radial expansion of the valve 30. In the typical deployment, the valve 30 will automatically fully expand to the deployment position shown in FIG. 10 when the tension is released from the tethers 124. For those situations in which the valve 30 does not automatically expand, or when the valve only partially expands, one or more alternative mechanisms and/or methods may be utilized to obtain full expansion. Several of these preferred mechanisms and methods are described below in Section B.

It is significant that, in the position shown in FIG. 10, the tethers 124 no longer interfere with the expansion of the valve 30, but they remain in control of the valve 30. In this position, it is possible to make any final positional adjustments of the valve 30, if necessary. This can be done by simply advancing or withdrawing the catheter 100, which tends to drag or push the valve 30 along with it. This may also be facilitated by slight advancement of the wrapping pin grip 154 and/or retraction of the tether grip 160, each of which actions will tend to apply tension to the tethers 154. In this manner, the valve position may be adjusted by the user while the valve is in its fully expanded state, under control of the tethers 124.

Alternatively, the valve 30 may be partially or fully contracted once again by increasing the tension on the tethers 124, as by retracting the tether grip 160 relative to the handle housing 152. (I.e., moving from position “d” to position “c” in FIG. 6). If necessary, the valve 30 may be fully contracted by retracting the tether grip 160, and then the deployment mechanism 104 may be fully restored to the undeployed position by simply reversing the above steps, in order. (I.e., moving to position “c”, then position “b”, then position “a”). This reversal of the process includes a step of advancing the wrapping pins 130 back over the contracted valve panels as the valve 30 is maintained in the “tri-star” shape. This process is facilitated by the presence of the tethers 124, which act as guides for the wrapping pins 130 to “ride up” over the edges of the valve panels under the guidance of the tethers 124. Once the wrapping pins 130 are in place, the slotted tube 110 is advanced over the valve 30, with each of the vertices of the valve “tri-star” extending through its respective slot 114. The slotted tube 110 is then rotated relative to the wrapping pins 130 and valve 30, causing the valve to transition to the fully contracted “tri-lobe” shape fully contained within the slotted tube 110. At that point, the delivery catheter may be removed from the patient without deploying the valve 30. Any or all of these adjustment or removal steps may be taken, depending upon the clinical need or depending upon any situation that may arise during the deployment procedure.

Turning to FIGS. 6 and 11, assuming that the valve 30 is placed in its final position and is ready to be released, the valve is released from the delivery catheter 100 by retracting the guidewire 108 to a position such that the distal end of the guidewire 108 no longer extends past the distal end of the nosecone 118 of the delivery catheter 100. At this point, the tethers 124 are released from their engagement with the guidewire 108. Preferably, the tethers 124 are then retracted at least into the wrapping pins 130, and may alternatively be fully retracted through and from the proximal end of the delivery catheter 100. This is reflected as handle position “f” in FIG. 6, in which the tether grip 160 is retracted at least to its initial position, and no change is made to the positions of either the wrapping pin grip 154 or the slotted tube grip 150. As shown in FIG. 11, the valve 30 is completely free from the delivery catheter 100. The nosecone 118 remains distal of the valve 30, and the nosecone shaft 136 extends through the body of the valve 30.

To complete the delivery process, the delivery catheter is preferably contracted to its pre-delivery state by advancing the wrapping pins 130 into engagement with the nosecone 118 by advancing the wrapping pin grip 154 on the handle back to position “a”, then by advancing the slotted tube 110 into engagement with the retainer ring 116 by advancing the slotted tube grip 150 on the handle back to position “a”. At this point, the delivery catheter 100 may be removed from the patient, leaving the prosthetic valve 30 in place.

B. Variations in Construction Components, and/or Features of Delivery Device

Preferred delivery catheters and methods of use are described above. A number of variations of several of the components, features, and other aspects of the device have been contemplated, and are described below.

Turning first to FIGS. 12A-B, an alternative method of connecting the tethers 124 to the guidewire 108 is shown. In the embodiment described above, the tethers 124 are looped over the guidewire 108. In the embodiment shown in FIGS. 12A-B, each tether 124 has an eyelet 125 formed at its distal end. The eyelet 125 is connected to the tether by an adhesive bond, or by crimping, or by any other suitable method. Each eyelet 125 has a hole formed at its distal end that is large enough to accommodate the guidewire 108 extending therethrough. The eyelet 125 may have a generally curved shape to rest alongside the nosecone 118, and a terminal end that is generally perpendicular to the longitudinal axis defined by the guidewire 108.

Turning to FIGS. 12C-D, an optional recess 131 may be formed in the distal end of each of the wrapping pins 130. The recess 131 is preferably formed having a shape and size to accommodate the eyelet 125 that is optionally provided at the distal end of each of the tethers 124. Accordingly, when no recess 131 is available (see, e.g., FIG. 12C), the eyelet 125 may be unable to be withdrawn into the lumen provided for passage of the tether 124. When a recess 131 is provided (see, e.g., FIG. 12D), the eyelet 125 is retracted into the recess 131 and does not extend out of the distal end of the wrapping pin 130.

FIG. 12E illustrates an embodiment including a plurality of dual or redundant tethers 124a-b. As shown in the Figure, a pair of tethers 124a-b are provided on each of the panels of the valve 30. The dual tethers 124a-b may be provided to increase tether strength, where needed, or to provide redundancy in the case of failure of one of the tethers. FIGS. 12F and 12G illustrate two possible methods for attaching the dual tethers 124a-b to a guidewire 108. In the first method, shown in FIG. 12F, a collar 176 is formed near the distal ends of and is attached to both of the tethers 124a-b near their distal ends, thereby forming a loop through which the guidewire 108 extends. In this construction, the loop will remain even if one of the tethers fails. In the second method, shown in FIG. 12G, each of the tethers 124a-b includes a separate attachment loop 178a-b, through which the guidewire 108 extends. In each method, the tethers 124a-b are released when they are disengaged from the guidewire 108 in the manner described above.

Turning to FIG. 13, a valve stop 142 may be provided on each of the tethers 124. Each valve stop 142 is in the form of a small cleat, barb, tab, or other transverse extension from the tether 124. The valve stop 142 is intended to provide another mechanism to prevent the valve 30 from slipping or migrating relative to the tethers 124 when the tethers 124 are in engagement with the valve 30. Thus, the valve stop 142 is located at a particular known position on each tether 124 to provide an optimal amount of control to the device 100 when the tethers 124 are engaged with the valve 30.

FIGS. 14A-B illustrate tethers formed of linkages 144 and tether sections 146. Each tether includes an eyelet 125 at its distal end connecting the tether to the guidewire 108. The eyelet 125 is connected directly to a first linkage member 144a, which may comprise a relatively rigid member formed of a metallic material, a rigid polymeric material, or the like. The linkage 144 is of a length sufficient to accommodate the valve 30 in its expanded state, as shown in FIG. 14A. The first linkage 144a is connected to a tether section 146 that extends through the length of the valve 30, and then connects to a second linkage member 144b. The second linkage member 144b then connects to another section of the tether 146, which extends proximally into the remainder of the delivery catheter. Each linkage member 144a, 144b includes a pivot at each end thereof, thereby enabling the linkage member 144a, 144b to pivot relative to the member to which it is attached. Thus, when the tethers are relaxed, the valve 30 is allowed to expand, as shown in FIG. 14A. However, when the tethers are pulled taut, the linkages 144a, 144b pivot, thereby causing the tethers to become taut and to convert the valve to its “tri-star” shape, as shown in FIG. 14B. Preferably, the nosecone 118 is provided with slots that accommodate the first linkage members 144a when they are pulled taut in the position shown in FIG. 14B.

FIG. 15 illustrates a slight variation of the preferred embodiment described above. In this embodiment, the tethers 124 each include a loop 148 formed on their distal ends. Each loop 148 is adapted to engage the guidewire 108. The tethers 124, in turn, are routed through throughholes 122 formed in the nosecone 118, as described above. Each tether 124 is then routed through a lumen formed in its respective wrapping pin 130. This particular routing orientation provides a mechanical advantage over other routing orientation because the tethers are captured by the nosecone 118 and wrapping pins 130 in close relation to the valve 30. This orientation also results in less migration of the tethers from side-to-side relative to the valve 30.

Turning next to FIGS. 16A-B, an alternative method for routing the tethers 124 in and around the nosecone 118 is to provide a plurality of slots 121 on the exterior of the nosecone 118. Each slot 121 is adapted to receive and retain a tether 124 when the tethers 124 are pulled taut. The slots 121 also allow the tethers to arise out of and disengage from its respective slot 121, for example, when the tethers 124 are slack and the valve 30 expands.

FIG. 17 illustrates another embodiment containing tethers formed of two separate components, including a thick, or broad primary tether 124a and a thin, or narrow secondary tether 124b. The primary tether 124a may be formed of a round or flat wire, and may be provided as either a straight component or it may be provided with a degree of shape memory. The secondary tether 124b may be made from a finer, smaller diameter material that is less traumatic to the vessel when it is pulled from between the valve 30 and the vessel. The secondary tether 124b may also be more easily retracted through the wrapping pins 130. Although a two-component tether 124 is shown, it should be appreciated that three or more components may also be incorporated to make up the tether 124 and to obtain various performance characteristics.

Turning next to FIGS. 18A-B, a pair of loops 170 are shown formed on the external surface of the valve 30. The loops 170 are intended to provide an engagement member on the surface of the valve 30 for the tethers 124 to engage to prevent the tethers 124 from migrating on the surface of the valve 30. For example, if the tether 124 migrates from the centerline of a valve panel 36, it may no longer have the ability to cause the valve panel 36 to invert or to restrain it in its inverted shape. By providing the loops 170, such migration of the tethers 124 is substantially prevented. It will be appreciated that mechanisms other than loops 170 may also be provided to restrain tether migration. For example, holes, barbs, slots, bumps, or other members may be provided on the surface or integrated into the body of the valve panel 36 to substantially restrain tether migration. One or more such members may be sufficient to provide sufficient restraining capability.

Turning to FIGS. 19A-D, several alternative wrapping pin embodiments are illustrated. The alternative embodiments represent several methods by which wrapping pin deflection may be overcome. As shown, for example, in FIG. 19A, when the wrapping pin hub 132 is rotated to cause wrapping up of a prosthetic valve 30 by the wrapping pins 130, an amount of torque “T” is imparted to the hub 132, and a corresponding deflecting force “F” is imparted to the distal end of the wrapping pin 130. The deflecting force “F” tends to cause the wrapping pin 130 to deflect in the direction of the deflecting force “F”, which tends to interfere with the wrapping procedure. To counteract the deflection force, the wrapping pin 130 may be formed having a gradual curving shape, as shown in FIG. 19B, to offset the deflection and to provide more even wrapping of the valve 30. The degree and nature of the curvature will vary depending upon the materials, sizes, and other properties of the delivery device and the valve, although the curvature will typically be directed toward the deflecting force. Alternatively, the wrapping pin 130 may be attached to the hub 132 at a fixed angle, or canted, as illustrated in FIG. 19C. Once again, the cant angle may be determined and will vary. Another alternative is shown in FIG. 19D, in which the wrapping pin 130 is provided with an offset between its proximal and distal ends. Once again, the degree of offset may be varied according to need for a given device.

Turning to FIGS. 20A-B, in several additional alternative embodiments, the wrapping pins 330 are not fixed in shape or orientation relative to the hub 332. In several such embodiments, the wrapping pins 330 include articulating segments 331 connected by rotating joints 332, thereby allowing each wrapping pin 330 to move radially relative to the longitudinal axis of the device. The concerted movement of the multiple wrapping pins 330 (three pins being preferred, but more or fewer also being possible) allows the structure to act as a gripper for manipulating the prosthetic valve 30. In the preferred embodiments, movement of each articulated wrapping pin 330 is independently controlled, thereby allowing the user to move each articulated wrapping pin 330 independently from a position generally comparable to that of the fixed wrapping pins 330 illustrated in the drawings (see FIG. 20A), to a position substantially radially outwardly spaced from the longitudinal axis of the device (see FIG. 20B). Thus, the close-in position (FIG. 20A) is suitable for restraining the valve in its contracted or “tri-star” shape, while the radially spaced position (FIG. 20B) is suitable for releasing the valve to its expanded state, or for retrieving the valve from its expanded state in order to transition the valve back to its contracted state.

FIGS. 21A-B illustrate an alternative construction for the slotted tube 110. In this construction, each of the longitudinal members 180 forming the slotted tube 110 includes an internal base portion 182 formed of a rigid material such as stainless steel or other metallic material, or a rigid polymeric material. The base portion 182 is intended to provide strength and resiliency to the slotted tube 110 to perform its functions of receiving, retaining, and manipulating the valve 30 in response to manipulations of the components contained on the handle mechanism 102 of the delivery catheter. Surrounding the base portion 182 of the slotted tube 110 are a number of air gaps 184 and/or filled sections 186 that are filled with a more flexible, less rigid material relative to the material forming the base portion 182. A wide variety of filler materials are possible, including several polymeric material such as polyurethane, or other soft materials such as one or more silicone based materials. The purpose for the air gaps 184 and/or filled portions 186 are to provide a less traumatic construction to reduce the likelihood of causing damage to the valve 30 or any of its panels 36 or hinges 52 while the valve is being loaded, stored, or deployed. By providing an air gap 184 or filled sections 186 on the edges of the longitudinal sections 180 of the slotted tube 110, the valve 30 is more protected during roll-up or deployment of the valve, during which time the edges of the longitudinal members 180 impose force against the valve panels 36 to cause them to roll up within the deployment mechanism 104 or to deploy out of the slotted tube 110.

Turning to FIG. 21C, another mechanism for protecting the valve panels 36 while they are retained within the slotted tube 110 is comprised of a series of runners 190 formed on the internal-facing surfaces of the longitudinal members 180 making up the slotted tube 110. The runners 190 provide a raised surface upon which the panels 36 will ride to minimize the contact between the panels 36 and the slotted tube 110. The runners 190 also serve to decrease friction between the two components and decrease the amount of abrasion that is imparted to the panels.

FIGS. 22A-B illustrate another alternative construction for a portion of the deployment mechanism 104 of the delivery catheter 100. In this alternative construction, the wrapping pins 130 are not needed. Instead, an inner slotted tube 194 is provided coaxially with and interior to the outer slotted tube 110. As the inner slotted tube 194 is rotated relative to the outer slotted tube 110, the valve 30 is converted from a “tri-star” shape to a “tri-lobe” shape, as shown, for example, in FIG. 22A. Reversing the relative rotation causes the valve 30 to extend out of the slots formed in each of the inner slotted tube 194 and the outer slotted tube 110 to form the “tri-star” shape shown in FIG. 22B. The valve 30 may then be deployed by retracting both the inner slotted tube 194 and the outer slotted tube 110 relative to the valve 30, thereby allowing the valve to expand to its deployed state.

FIGS. 23A-C illustrate an optional shape set nosecone shaft 136. The shape set nosecone shaft 136 includes a pre-set shape formed into the distal end of the nosecone shaft 136 to facilitate the ability for the distal end of the delivery catheter 100 to pass over the aortic arch. This is particularly useful when the delivery catheter 100 is used for delivery of a prosthetic aortic valve. The shape set shown in FIG. 23A is generally in the form of a hook-shape, although other shapes is possible in order to improve the performance of the catheter. The shape set is also useful to stabilize the position of the catheter once it is delivered over the aortic arch. The shape set may be imparted by any mechanical or other method known to those skilled in the art. An optional tensioning member 336 may be provided on the external surface of the nosecone shaft 136. The tensioning member 336 is used to straighten the curvature of the shape set nosecone shaft 136 under the user's control. For example, as a tension force “T” is imparted to the tensioning member 336, such as by the user pulling proximally on the tensioning member 336 from the handle mechanism 102, the nosecone shaft 136 is straightened, as shown in FIG. 23C. The operation of the tensioning member 336 thereby provides the ability to manipulate the distal end of the delivery catheter 100 in a manner that provides an ability for the user to effectively steer the catheter over difficult or tortuous portions of the patient's vasculature. Other uses of the tensioning member 336 are described elsewhere herein.

C. Active Deployment of Undeployed and Not-Fully Deployed Valves

Although typically a prosthetic valve 30 such as those illustrated and described above in relation to FIGS. 1A-C—and those described in the '126 application and elsewhere—will fully deploy once it is released from the delivery catheter, it sometimes occurs that the valve does not deploy, or does not fully deploy. In most of these circumstances, the failure to deploy or to fully deploy is due to the fact that one or more panels 36 of a multi-panel valve 30 fails to change from its inverted state to its expanded state. One such example is illustrated in FIG. 24B, in which two panels 36 of a three-panel prosthetic valve 30 have expanded, but the upper panel 36 remains in a partially inverted state. Several mechanisms and methods for actively correcting these undeployed and not-fully deployed valves are described herein.

Several of the described mechanisms take advantage of the fact that, in most circumstances of non-full deployment, only a point contact is needed to cause the valve to fully expand. Accordingly, it may not be necessary to fully occlude the vessel in order to cause the valve or similar prosthetic device to fully expand. Thus, in most of the mechanisms and methods described, fluid flow or perfusion is still allowed through the valve and vessel as the active deployment procedure takes place. This is to be distinguished from the deployment methods applicable to most stent-like prosthetic devices in which fibrillation is induced to decrease flow during the deployment procedure. No such fibrillation is required for delivery and deployment of the prosthetic valves and similar devices described herein, nor for the active deployment mechanisms and methods described.

Turning to FIGS. 24A-C, a first such mechanism 200 includes a collar 202 and a plurality of wire forms 204 extending proximally from the collar 202. The mechanism 200 is intended to ride closely along the nosecone shaft 136 on any of the embodiments of the delivery catheter 100 described herein. As the mechanism 200 is advanced distally, it will enter and pass through the body of the partially-expanded valve 30. Once it is located there, the collar 202 may be retracted proximally, as shown by the arrow “A” in FIG. 24A, thereby causing the wire forms 204 to bow radially outward, (see, e.g., FIGS. 24A and 24C), engaging any inverted panels 36 of the valve 30 and causing them to expand to the fully expanded state. Preferably, the collar 202 is retracted by a tether or other control member that is connected to the collar 202 and that extends proximally to the handle where it can be manipulated by the user. Once the valve 30 is fully expanded, the collar 202 is advanced distally to cause the wire forms 204 to return to their unbowed state. The mechanism 200 may then be retracted into the delivery catheter 100. In alternative embodiments, the collar 202 may be provided with threads that engage threads formed on the nosecone shaft 136. Any other engagement providing relative movement between the collar 202 and the nosecone shaft 136 is also suitable.

As an alternative to the wire forms 204 shown in the above embodiment, a continuous segment of metallic or polymeric material having sufficient elasticity to expand and contract in the manner shown may be used. Other alternatives including using only a single band or material, or two, three, or more bands. Other alternative constructions and materials capable of expanding and contracting in the involved space internal of the undeployed or partially deployed prosthetic valve 30 are also contemplated, and are suitable for use as the active deployment mechanism 200 described herein.

Another alternative construction for the active deployment mechanism is illustrated in FIGS. 25A-C. A partially deployed valve 30 includes an upper panel 36 that has not yet fully deployed. The deployment mechanism 200 comprises a collar 212 and a plurality of wire forms 214 extending proximally from the collar 212. Prior to use, the collar 212 is located internally of the catheter shaft 106 along the nosecone shaft 136, and the wire forms 214 lie flat along the nosecone shaft 136 proximally to the collar 212. (See FIG. 25A). The collar 212 is advanced distally through the partially deployed valve 30 until the collar 212 engages the proximal side of the nosecone 118, where further distal advancement is stopped. (See FIG. 25B). As additional distal-oriented force is applied to the mechanism 200, the wire forms 214 are caused to bow radially outward within the valve 30 to cause the upper panel 36 to fully deploy, as shown in FIG. 25C. The mechanism 200 is then collapsed and retracted proximally.

Turning to FIGS. 26A-E, several alternative balloon-based active deployment mechanism are described. The balloon-based systems include use of a balloon or other expandable member to cause an otherwise non-fully deployed valve 30 to expand to its fully expanded state upon deployment. Preferably, each of the balloons described herein includes an inflation lumen that is communicatively connected to the handle mechanism 102 or otherwise provided with a mechanism for selectively inflating the balloon(s) as needed.

FIG. 26A illustrates a first embodiment in which a balloon 220 is provided internally of a prosthetic valve 30. The balloon 220 includes a pair of broad portions 222a that correspond with the proximal and distal ends of the valve 30, and a narrowed waist portion 222b that corresponds with the middle portion of the valve 30. The balloon 220 may optionally be provided in a fixed relationship with the valve body, as illustrated in FIG. 26B, wherein the balloon 220 is packaged with the valve 30 as the valve 30 is loaded into the delivery catheter and delivered to a treatment location. Thus, if the valve 30 is found not to have fully expanded after deployment, the balloon 220 may be inflated to cause full deployment.

A number of optional balloon shapes and sizes are illustrated in FIGS. 26C-E. For example, in FIG. 26C, a single balloon 220 is shown having two large diameter portions 222a and a narrow, or smaller diameter portion 222b connecting the other two portions. In FIG. 26D, a single balloon 220 is shown, and would preferably extend through the entire length of the valve 30. In FIG. 26E, three separate balloons 220a-c are illustrated in an offset-tangent arrangement. The offset-tangent arrangement provides a number of benefits, including the ability to selectively inflate only one or more of the balloons 220a-c depending upon which valve panel 36 requires expansion. Also, the offset-tangent arrangement removes the need to fully occlude the vessel, thereby allowing fluid to flow around the balloon structure.

Turning to FIGS. 27A-B, in another alternative arrangement, a pair of toroidal balloons 226 are attached to the external surface of a prosthetic valve 30 near its proximal and distal ends, respectively. The pair of toroidal balloons 226 may be selectively expandable in order to actively deploy an otherwise non-fully deployed prosthetic valve 30. Upon expansion of the valve, the balloons 226 may then be deflated and left in place to serve as a seal against the vessel wall 230, as shown in FIG. 27B. Alternatively, the toroidal balloons 226 may be attached to the internal wall of the prosthetic valve 30, and may then be selectively detached from the valve 30 after the valve has been fully deployed.

FIG. 28 illustrates another active deployment mechanism 234 that includes a roller member 236 and a pincher member 238, each of which may be included on the distal end of a shaft that may be included with, or separate from, the delivery catheter 100. The roller 236 and pincher 238 advance along a panel 36 until the components encounter a hinge 52. Because of the diameter of the roller 236 relative to the hinge 52, when the roller 236 and pincher 238 engage the hinge 52, they force the hinge 52 to open, thereby causing the valve panel 36 to fully deploy.

FIGS. 29A-B illustrate yet another deployment mechanism 242 that includes a wedge-shaped member having an upper guide 244 and a lower separator 246. As with the previous deployment mechanism 234, the present embodiment 242 be included on the distal end of a shaft that may be included with, or separate from, the delivery catheter 100. The wedge mechanism 242 is intended to be guided onto each of the hinges 52 of the undeployed or not-fully deployed valve 30. Because of the relative size and shape of the separator 246 portion of the wedge, the separator 246 causes the hinges 52 to open, thereby causing the valve panels 36 to expand to the fully deployed state.

Turning next to FIG. 30, another deployment mechanism 250 includes a torsion spring 252 mounted to the internal surface of the valve 30. The torsion spring 252 may be integrated into and/or may form part of the hinge 52 of the valve 30, but is provided with a pair of arms 254 that extend into the interior of the valve 30, and which are biased to force the valve panels 36 radially outward to fully deploy the valve 30. The torsion spring 252 may be formed integrally with the valve 30, in which case it remains in place after valve deployment.

Turning to FIGS. 31A-B, yet another active valve deployment mechanism 256 includes a membrane balloon 258 formed on or attached to the external surface of each of the longitudinal members 180 of the slotted tube 110. The membrane balloons 258 are selectively and independently inflatable, as needed to actively deploy one or more undeployed panels of a prosthetic valve 10. As shown in FIG. 31A, the slotted tube 110 is first inserted into the valve 30, then one or more of the membrane balloons 258 is expanded. The expansion is initially to a first state 260 in which the membrane balloon engages the valve body panels 36, then, ultimately, to a second state 262 corresponding with full valve deployment. After deployment, the balloon may be deflated and the device removed from the patient's vasculature.

Turning to FIG. 32, a still further alternative active valve deployment mechanism 266 includes a plurality of (preferably three) linkage members 268, each including a pivot 270 allowing the linkage member to expand radially, such as under the expansion force of an internal balloon 272 or other expandable member. Thus, as the deployment mechanism 266 is inserted into the undeployed prosthetic valve 30, it is able to be expanded by expanding or inflating the balloon 272.

FIGS. 33A-B illustrate another active deployment mechanism 276 that incorporates a balloon 278 or other expandable member that is formed within the internal volume of the nosecone 118. In its undeployed state, shown in FIG. 33A, the balloon 278 does not extend past the distal end of the nosecone 118. However, if needed to expand the undeployed or not-fully deployed valve 30, the balloon 278 is expanded, as shown in FIG. 33B, thereby expanding the valve 30 to its expanded state.

FIGS. 34A-C illustrate an active deployment mechanism that includes a yoke 282 that is slidably engaged over the nosecone shaft 136. A set of rotating linkages 284a-f are connected to the sliding yoke 282 such that, when the yoke 282 slides proximally along the nosecone shaft 136, as shown by the arrows “A” in FIG. 34A, the linkages 284a-f extend radially outward from the shaft 136. In the preferred embodiment, the free ends 284d-f of each of the linkages 284a-f are selectively attached to a respective panel of the valve 30 by a temporary mechanism. For example, the free ends 284d-f of the linkages may be attached to the valve panels by the tethers 124, such that when the tethers 124 are retracted, the valve panels are released from the linkages 284a-f. The nosecone 118 is preferably hollow to accommodate the mechanism prior to deployment.

Another optional active deployment mechanism utilizes the shape set nosecone shaft 136 and tensioning member 336 shown in FIGS. 23A-C. In the case of a valve 30 that does not fully deploy, it may be possible to manipulate the tensioning member 336 to cause either the nosecone 118, the nosecone shaft 136, or some other portion of the deployment mechanism 104 to engage the undeployed portion of the valve sufficiently to cause it to fully deploy. In a particularly preferred method, the tethers 124 associated with all of the fully deployed panels are allowed to remain slack, while the tether 124 associated with the undeployed panel is pulled taut to apply tension to the tether. By doing so, the nosecone 118 and the respective wrapping pin 130 are pulled to the respective distal and proximal edges of the valve panel, creating a relatively rigid linkage between the components. Once this is done, the tensioning member 336 (or other suitable steering mechanism) is actuated in order to cause the relatively rigid linkage to bias the still-inverted panel radially outward to the expanded position. This process may be repeated for each panel that is not fully expanded.

Finally, another alternative active deployment mechanism is to pressurize the aorta (or other treatment vessel) to cause the tissue defining the vessel to expand, thereby providing an adequate (increased) volume within which the valve 30 or other device is able to expand to its fully expanded state. Pressurization of the aorta (or other vessel) may be obtained by simply occluding the vessel, or by actively pressuring the vessel using an external source.

The preferred embodiments of the inventions that are the subject of this application are described above in detail for the purpose of setting forth a complete disclosure and for the sake of explanation and clarity. Those skilled in the art will envision other modifications within the scope and spirit of the present disclosure. Such alternatives, additions, modifications, and improvements may be made without departing from the scope of the present inventions, which is defined by the claims.

Claims

1. A method of using a delivery device for an expandable prosthetic heart valve, comprising: percutaneously inserting a delivery device into a patient's body, wherein the delivery device is coupled with an expandable prosthetic heart valve having a distal end and a proximal end, the delivery device comprising a plurality of retaining members and a plurality of elongate tethers positioned to allow manipulation of the expandable prosthetic heart valve;expanding the expandable prosthetic heart valve from a contracted state to an expanded state;increasing a tension on the plurality of tethers from a state where each elongate tether contacts both the distal end and the proximal end of the expandable prosthetic heart valve such that the expandable prosthetic heart valve is at least partially contracted towards a central, longitudinal axis of the delivery device;advancing the plurality of retaining members in the same direction over the prosthetic heart valve after increasing the tension on the plurality of elongate tethers and prior to adjusting the position of the prosthetic heart valve;adjusting the position of the expandable prosthetic heart valve while at least partially contracted; anddecreasing the tension on the plurality of elongate tethers after adjusting the position of the prosthetic heart valve.
2. The method of claim 1, wherein expanding the prosthetic heart valve comprises expanding the prosthetic heart valve into contact with a vessel wall of a blood vessel of the patient.
3. The method of claim 2, wherein the blood vessel is the aorta.
4. The method of claim 1, wherein the plurality of tethers are engaged with the prosthetic heart valve through a hole in a support structure of the prosthetic heart valve.
5. The method of claim 1, wherein the prosthetic heart valve comprises a support structure coupled with a valvular body, the support structure comprising a plurality of independently invertible panels, and wherein increasing the tension on at least one of the plurality of elongate tethers comprises at least partially inverting at least one of the independently invertible panels.
6. The method of claim 5, wherein increasing the tension on at least one of the plurality of elongate tethers comprises fully inverting at least one of the independently invertible panels.
7. The method of claim 5, wherein the plurality of invertible panels are concave in the contracted state and convex in the expanded state, and wherein each of the plurality of invertible panels can be independently contracted and expanded.
8. The method of claim 5, wherein the independently invertible panels comprise nitinol.
9. The method of claim 1, wherein each tether comprises a polymeric material.
10. The method of claim 1, wherein the plurality of tethers are routed over and past both the proximal end and the distal end of the prosthetic heart valve.
11. The method of claim 1, further comprising adjusting the position of the delivery device after decreasing the tension on the plurality of tethers, such that the position of the prosthetic heart valve is again adjusted.
12. The method of claim 1, wherein the prosthetic heart valve is fully contracted by increasing the tension on each of the plurality of tethers of each of a plurality of independently invertible panels.
13. The method of claim 1, wherein decreasing the tension on the plurality of tethers allows the prosthetic heart valve to self-expand.
14. The method of claim 1, further comprising expanding the prosthetic heart valve with an expansion member after decreasing the tension on the plurality of tethers.
15. The method of claim 1, wherein the tension on each of the plurality of tethers is independently adjustable.
16. The method of claim 1, wherein at least one of the plurality of elongate tethers is configured to retain the prosthetic heart valve after expanding the implant.
17. The method of claim 16, wherein decreasing the tension comprises releasing the at least one of the plurality of elongate tethers from the prosthetic heart valve, the method further comprising removing the delivery device while the prosthetic heart valve remains in position within the patient's body.
18. A method of using a delivery device for an expandable prosthetic heart valve, comprising: percutaneously inserting a delivery device into a patient's body, wherein the delivery device is coupled with an expandable prosthetic heart valve having a distal end and a proximal end, the delivery device comprising a plurality of elongate tethers positioned to allow manipulation of the expandable prosthetic heart valve, the prosthetic heart valve comprising a support structure coupled with a valvular body, the support structure comprising a plurality of independently invertible panels, wherein increasing the tension on at least one of the plurality of elongate tethers comprises at least partially inverting at least one of the independently invertible panels, wherein the delivery device is percutaneously inserted over a guidewire and one of the plurality of tethers is routed over each of the plurality of independently invertible panels, around the guidewire and back over each of the plurality of independently invertible panels;expanding the expandable prosthetic heart valve from a contracted state to an expanded state;increasing a tension on the plurality of tethers from a state where each elongate tether contacts both the distal end and the proximal end of the expandable prosthetic heart valve such that the expandable prosthetic heart valve is at least partially contracted towards a central, longitudinal axis of the delivery device;adjusting the position of the expandable prosthetic heart valve while at least partially contracted; anddecreasing the tension on the plurality of elongate tethers after adjusting the position of the prosthetic heart valve.

US Referenced Citations (309)

Number	Name	Date	Kind
376531	Byrnes	Jan 1888	A
1314601	McCaskey	Sep 1919	A
3579642	Hefferman	May 1971	A
3587115	Shiley	Jun 1971	A
3657744	Ersek	Apr 1972	A
3671979	Moulopoulos	Jun 1972	A
3755823	Hancock	Sep 1973	A
3867728	Stubstad et al.	Feb 1975	A
4056854	Boretos et al.	Nov 1977	A
4106129	Carpentier et al.	Aug 1978	A
4328839	Lyons et al.	May 1982	A
4339831	Johnson	Jul 1982	A
4340091	Skelton et al.	Jul 1982	A
4624822	Arru et al.	Nov 1986	A
4655218	Kulik et al.	Apr 1987	A
4683883	Martin	Aug 1987	A
4692165	Bokros	Sep 1987	A
4758151	Arru et al.	Jul 1988	A
4822345	Danforth	Apr 1989	A
4822353	Bokros	Apr 1989	A
4856516	Hillstead	Aug 1989	A
4878495	Grayzel	Nov 1989	A
4878906	Lindemann et al.	Nov 1989	A
4960424	Grooters	Oct 1990	A
4994077	Dobben	Feb 1991	A
5002567	Bona et al.	Mar 1991	A
5037434	Lane	Aug 1991	A
5078737	Bona et al.	Jan 1992	A
5098374	Othel-Jacobsen et al.	Mar 1992	A
5123919	Sauter et al.	Jun 1992	A
5163953	Vince	Nov 1992	A
5163954	Curcio et al.	Nov 1992	A
5201757	Heyn et al.	Apr 1993	A
5213580	Slepian et al.	May 1993	A
5238454	Schmidt	Aug 1993	A
5326371	Love et al.	Jul 1994	A
5328471	Slepian	Jul 1994	A
5370685	Stevens	Dec 1994	A
5397348	Campbell et al.	Mar 1995	A
5397351	Pavcnik et al.	Mar 1995	A
5403305	Sauter et al.	Apr 1995	A
5411552	Andersen et al.	May 1995	A
5423886	Arru et al.	Jun 1995	A
5443474	Sfakianos et al.	Aug 1995	A
5454838	Vallana et al.	Oct 1995	A
5522885	Love et al.	Jun 1996	A
5531094	More et al.	Jul 1996	A
5545214	Stevens	Aug 1996	A
5554185	Block et al.	Sep 1996	A
5560487	Starr	Oct 1996	A
5582607	Lackman	Dec 1996	A
5607442	Fischell et al.	Mar 1997	A
5620456	Sauer et al.	Apr 1997	A
5668425	Marioni et al.	Sep 1997	A
5695515	Orejola	Dec 1997	A
5713860	Kaplan et al.	Feb 1998	A
5713953	Vallana et al.	Feb 1998	A
5716370	Williamson, IV et al.	Feb 1998	A
5724705	Hauser	Mar 1998	A
5814097	Sterman et al.	Sep 1998	A
5823342	Caudillo et al.	Oct 1998	A
5840081	Andersen et al.	Nov 1998	A
5855601	Bessler et al.	Jan 1999	A
5868708	Hart et al.	Feb 1999	A
5891195	Klostermeyer et al.	Apr 1999	A
5919225	Lau et al.	Jul 1999	A
5921993	Yoon	Jul 1999	A
5925063	Khosravi	Jul 1999	A
5957949	Leonhardt et al.	Sep 1999	A
5980570	Simpson	Nov 1999	A
5984959	Robertson et al.	Nov 1999	A
6027779	Campbell et al.	Feb 2000	A
6042607	Williamson, IV et al.	Mar 2000	A
6051014	Jang	Apr 2000	A
6053922	Krause et al.	Apr 2000	A
6090138	Chasak et al.	Jul 2000	A
6092529	Cox	Jul 2000	A
6093530	McIlroy et al.	Jul 2000	A
6102944	Huynh et al.	Aug 2000	A
6102945	Campbell	Aug 2000	A
6117169	Moe	Sep 2000	A
6132986	Pathak et al.	Oct 2000	A
6143024	Campbell et al.	Nov 2000	A
6143025	Stobie et al.	Nov 2000	A
6162172	Cosgrove et al.	Dec 2000	A
6168614	Andersen et al.	Jan 2001	B1
6174331	Moe et al.	Jan 2001	B1
6182664	Cosgrove	Feb 2001	B1
6197053	Cosgrove et al.	Mar 2001	B1
6199696	Lytle et al.	Mar 2001	B1
6206918	Campbell et al.	Mar 2001	B1
6217610	Carpentier et al.	Apr 2001	B1
6221096	Aiba et al.	Apr 2001	B1
6231578	Rajhansa	May 2001	B1
6231602	Carpentier et al.	May 2001	B1
6241765	Griffin et al.	Jun 2001	B1
6270526	Cox	Aug 2001	B1
6283995	Moe et al.	Sep 2001	B1
6287339	Vazquez et al.	Sep 2001	B1
6299637	Shaolian et al.	Oct 2001	B1
6299638	Sauter	Oct 2001	B1
6338740	Carpentier	Jan 2002	B1
6342070	Nguyen-Thien-Nhon	Jan 2002	B1
6348068	Campbell et al.	Feb 2002	B1
6350281	Rhee	Feb 2002	B1
6350732	Moore et al.	Feb 2002	B1
6364905	Simpson et al.	Apr 2002	B1
6371983	Lane	Apr 2002	B1
6383147	Stobie	May 2002	B1
6391054	Carpentier et al.	May 2002	B2
6402780	Williamson, IV et al.	Jun 2002	B2
6405084	Plicchi et al.	Jun 2002	B2
6409758	Stobie et al.	Jun 2002	B2
6425916	Garrison et al.	Jul 2002	B1
6453062	MacNutt et al.	Sep 2002	B1
6454799	Schreck	Sep 2002	B1
6458155	Van Nguyen et al.	Oct 2002	B1
6461382	Cao	Oct 2002	B1
6475239	Campbell et al.	Nov 2002	B1
6479079	Pathak et al.	Nov 2002	B1
6482228	Norred	Nov 2002	B1
6485512	Cheng	Nov 2002	B1
6493585	Plicchi et al.	Dec 2002	B2
6530952	Vesely	Mar 2003	B2
6544279	Hopkins et al.	Apr 2003	B1
6558418	Carpentier et al.	May 2003	B2
6565602	Rolando et al.	May 2003	B2
6569196	Vesely	May 2003	B1
6572642	Rinaldi et al.	Jun 2003	B2
6582462	Andersen et al.	Jun 2003	B1
6585632	Vallana et al.	Jul 2003	B2
6585766	Huynh et al.	Jul 2003	B1
6596471	Pathak et al.	Jul 2003	B2
6602288	Cosgrove et al.	Aug 2003	B1
6613085	Anderson et al.	Sep 2003	B1
6616690	Rolando et al.	Sep 2003	B2
6635085	Caffey et al.	Oct 2003	B1
6638303	Campbell	Oct 2003	B1
6652578	Bailey et al.	Nov 2003	B2
6663667	Dehdashtian et al.	Dec 2003	B2
6673109	Cox	Jan 2004	B2
6679871	Hahnen	Jan 2004	B2
6682543	Barbut et al.	Jan 2004	B2
6682558	Tu et al.	Jan 2004	B2
6682559	Myers et al.	Jan 2004	B2
6689149	Maahs	Feb 2004	B2
6692512	Jang	Feb 2004	B2
6706033	Martinez et al.	Mar 2004	B1
6719787	Cox	Apr 2004	B2
6719788	Cox	Apr 2004	B2
6719789	Cox	Apr 2004	B2
6723122	Yang et al.	Apr 2004	B2
6730118	Spenser et al.	May 2004	B2
6733513	Boyle et al.	May 2004	B2
6733525	Yang et al.	May 2004	B2
6736845	Marquez et al.	May 2004	B2
6736846	Cox	May 2004	B2
6767362	Schreck	Jul 2004	B2
6770083	Seguin	Aug 2004	B2
6783988	Dinh et al.	Aug 2004	B1
6790219	Murphy	Sep 2004	B1
6796972	Sinofsky et al.	Sep 2004	B1
6797000	Simpson et al.	Sep 2004	B2
6805710	Bolling et al.	Oct 2004	B2
6821279	Di Emidio	Nov 2004	B2
6821297	Snyders	Nov 2004	B2
6846324	Stobie	Jan 2005	B2
6849088	Dehdashtian et al.	Feb 2005	B2
6858039	McCarthy	Feb 2005	B2
6875231	Anduiza et al.	Apr 2005	B2
6878168	Carpentier et al.	Apr 2005	B2
6893459	Macoviak	May 2005	B1
6893460	Spenser et al.	May 2005	B2
6896698	Rolando et al.	May 2005	B2
6908481	Cribier	Jun 2005	B2
6939365	Fogarty et al.	Sep 2005	B1
6945997	Huynh et al.	Sep 2005	B2
6951571	Srivastava	Oct 2005	B1
6962605	Cosgrove et al.	Nov 2005	B2
6986775	Morales et al.	Jan 2006	B2
6988881	Motsenbocker et al.	Jan 2006	B2
6989028	Lashinski et al.	Jan 2006	B2
7004176	Lau	Feb 2006	B2
7011669	Kimblad	Mar 2006	B2
7011681	Vesely	Mar 2006	B2
7011682	Lashinski et al.	Mar 2006	B2
7014648	Ambrisco et al.	Mar 2006	B2
7018406	Seguin et al.	Mar 2006	B2
7033390	Johnson et al.	Apr 2006	B2
7041132	Quijano et al.	May 2006	B2
7060092	Kuribayashi et al.	Jun 2006	B2
7252682	Seguin	Aug 2007	B2
7320704	Lashinski et al.	Jan 2008	B2
7374571	Pease et al.	May 2008	B2
7429270	Baumgartner et al.	Sep 2008	B2
20010016758	Plicchi et al.	Aug 2001	A1
20010018600	Plicchi et al.	Aug 2001	A1
20010039450	Pavcnik et al.	Nov 2001	A1
20010049541	Plicchi et al.	Dec 2001	A1
20020032482	Cox	Mar 2002	A1
20020038128	Turovkiy et al.	Mar 2002	A1
20020042651	Liddicoat et al.	Apr 2002	A1
20020052647	Rolando et al.	May 2002	A1
20020055775	Carpentier et al.	May 2002	A1
20020058994	Hill et al.	May 2002	A1
20020072793	Rolando et al.	Jun 2002	A1
20020095173	Mazzocchi et al.	Jul 2002	A1
20020099441	Dehdashtian	Jul 2002	A1
20020117264	Rinaldi et al.	Aug 2002	A1
20020133226	Marquez et al.	Sep 2002	A1
20020138138	Yang	Sep 2002	A1
20020161431	Stobie et al.	Oct 2002	A1
20020163104	Motsenbocker et al.	Nov 2002	A1
20020183766	Seguin	Dec 2002	A1
20020183831	Rolando et al.	Dec 2002	A1
20030009076	Vallana et al.	Jan 2003	A1
20030023262	Welch	Jan 2003	A1
20030027332	Lafrance et al.	Feb 2003	A1
20030033002	Dehdashtian et al.	Feb 2003	A1
20030036795	Andersen et al.	Feb 2003	A1
20030050694	Yang et al.	Mar 2003	A1
20030055495	Pease et al.	Mar 2003	A1
20030065356	Tsugita et al.	Apr 2003	A1
20030114913	Spenser et al.	Jun 2003	A1
20030114917	Holloway et al.	Jun 2003	A1
20030125793	Vesely	Jul 2003	A1
20030130721	Martin et al.	Jul 2003	A1
20030153943	Michael et al.	Aug 2003	A1
20030153946	Kimblad	Aug 2003	A1
20030195613	Curcio et al.	Oct 2003	A1
20030212433	Ambrisco et al.	Nov 2003	A1
20040015224	Armstrong et al.	Jan 2004	A1
20040024451	Johnson et al.	Feb 2004	A1
20040030382	St. Goar et al.	Feb 2004	A1
20040034380	Woolfson et al.	Feb 2004	A1
20040049266	Anduiza et al.	Mar 2004	A1
20040078074	Anderson et al.	Apr 2004	A1
20040087965	Levine et al.	May 2004	A1
20040092858	Wilson et al.	May 2004	A1
20040092989	Wilson et al.	May 2004	A1
20040093060	Seguin et al.	May 2004	A1
20040093080	Helmus et al.	May 2004	A1
20040127979	Wilson et al.	Jul 2004	A1
20040148017	Stobie	Jul 2004	A1
20040148018	Carpentier et al.	Jul 2004	A1
20040153140	Rolando et al.	Aug 2004	A1
20040158276	Barbut et al.	Aug 2004	A1
20040172124	Vallana et al.	Sep 2004	A1
20040186563	Lobbi	Sep 2004	A1
20040199245	Lauterjung	Oct 2004	A1
20040210304	Seguin et al.	Oct 2004	A1
20040225352	Osborne et al.	Nov 2004	A1
20040243222	Osborne et al.	Dec 2004	A1
20040249433	Freitag	Dec 2004	A1
20050027337	Rudko et al.	Feb 2005	A1
20050033398	Seguin	Feb 2005	A1
20050038497	Neuendorf et al.	Feb 2005	A1
20050043760	Fogarty et al.	Feb 2005	A1
20050043790	Seguin	Feb 2005	A1
20050043792	Solem et al.	Feb 2005	A1
20050065594	DiMatteo et al.	Mar 2005	A1
20050075584	Cali	Apr 2005	A1
20050075712	Biancucci et al.	Apr 2005	A1
20050075725	Rowe	Apr 2005	A1
20050090888	Hines et al.	Apr 2005	A1
20050096734	Majercak et al.	May 2005	A1
20050096740	Langberg et al.	May 2005	A1
20050137686	Salahieh et al.	Jun 2005	A1
20050137687	Salahieh et al.	Jun 2005	A1
20050137688	Salahieh et al.	Jun 2005	A1
20050137689	Salahieh et al.	Jun 2005	A1
20050137690	Salahieh et al.	Jun 2005	A1
20050137691	Salahieh et al.	Jun 2005	A1
20050137695	Salahieh et al.	Jun 2005	A1
20050137696	Salahieh et al.	Jun 2005	A1
20050137699	Salahieh et al.	Jun 2005	A1
20050137701	Salahieh et al.	Jun 2005	A1
20050143809	Salahieh et al.	Jun 2005	A1
20050187616	Realyvasquez	Aug 2005	A1
20050197695	Stacchino et al.	Sep 2005	A1
20050203614	Forster et al.	Sep 2005	A1
20050203615	Forster et al.	Sep 2005	A1
20050203617	Forster et al.	Sep 2005	A1
20050204617	Sowers	Sep 2005	A1
20050228485	Rolando et al.	Oct 2005	A1
20050228495	Macoviak	Oct 2005	A1
20050267493	Schreck et al.	Dec 2005	A1
20050277959	Cosgrove et al.	Dec 2005	A1
20050283231	Haug et al.	Dec 2005	A1
20050288764	Snow et al.	Dec 2005	A1
20060004442	Spenser et al.	Jan 2006	A1
20060015179	Bulman-Fleming et al.	Jan 2006	A1
20060025854	Lashinski et al.	Feb 2006	A1
20060025855	Lashinski et al.	Feb 2006	A1
20060052867	Revuelta et al.	Mar 2006	A1
20060058871	Zakay et al.	Mar 2006	A1
20060069424	Acosta et al.	Mar 2006	A1
20060074484	Huber	Apr 2006	A1
20060095052	Chambers	May 2006	A1
20060122633	To et al.	Jun 2006	A1
20060173537	Yang et al.	Aug 2006	A1
20060217764	Abbott et al.	Sep 2006	A1
20060235509	Lafontaine	Oct 2006	A1
20070016286	Herrmann et al.	Jan 2007	A1
20070016288	Gurskis et al.	Jan 2007	A1
20070088431	Bourang et al.	Apr 2007	A1
20070185571	Kapadia et al.	Aug 2007	A1
20080077234	Styrc	Mar 2008	A1
20080140172	Carpenter et al.	Jun 2008	A1

Foreign Referenced Citations (11)

Number	Date	Country
WO 9117730	Nov 1991	WO
WO 9933414	Jul 1999	WO
WO 0176510	Oct 2001	WO
WO 03003949	Jan 2003	WO
WO 03047468	Jun 2003	WO
WO 2003096932	Nov 2003	WO
WO 03105670	Dec 2003	WO
WO 2005009285	Feb 2005	WO
WO 2005076973	Aug 2005	WO
WO 2005087140	Sep 2005	WO
WO 2006066150	Jun 2006	WO

Non-Patent Literature Citations (27)

Entry
U.S. Appl. No. 11/066,126—Office Action, Dec. 22, 2009.
U.S. Appl. No. 11/066,126—Office Action, Oct. 16, 2008.
U.S. Appl. No. 11/066,126—Office Action, Apr. 3, 2009.
U.S. Appl. No. 11/066,124—Office Action, Mar. 7, 2007.
U.S. Appl. No. 11/066,124—Office Action, Mar. 7, 2008.
U.S. Appl. No. 11/066,124—Office Action, Oct. 2, 2008.
U.S. Appl. No. 11/066,124—Office Action Jun. 9, 2009.
U.S. Appl. No. 11/067,330—Office Action, Apr. 16, 2007.
U.S. Appl. No. 11/067,330—Office Action, Jun. 11, 2008.
U.S. Appl. No. 11/067,330—Office Action, Jun. 10, 2009.
U.S. Appl. No. 11/364,715—Office Action, Dec. 11, 2006.
U.S. Appl. No. 11/364,715—Office Action, Oct. 18, 2007.
U.S. Appl. No. 11/364,715—Office Action, Jan. 12, 2009.
Ser. No. 200580012735.5—Office Action, Jan. 9, 2009.
Ser. No. 200580012735.5—Office Action, Jul. 10, 2009.
Ser. No. 05723873.5—ESR, Nov. 3, 2009.
Ser. No. WO2007/101159—ISR, Apr. 24, 2008.
Ser. No. WO2007/101160—ISR, Dec. 11, 2007.
Ser. No. WO2007/149905—ISR, Aug. 29, 2008.
Ser. No. WO2007/149841—ISR, Jul. 30, 2008.
Ser. No. WO2007/149933—ISR, Aug. 15, 2008.
Ser. No. WO2007/149910—ISR, Jan. 28, 2008.
Ser. No. WO2008/030946—ISR, Jan. 11, 2008.
European Search Report, Appln. No. 07798835.0-2320, Mar. 2, 2010.
European Search Report, Appln. No. 0781489.9-2320, Mar. 3, 2010.
European Search Report, Appln. No. 07798822.2-2320, Mar. 8, 2010.
European Search Report, Appln. No. 07757493.7-2320, Mar. 15, 2010.

Related Publications (1)

	Number	Date	Country
	20070203561 A1	Aug 2007	US

Methods and devices for delivery of prosthetic heart valves and other prosthetics

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications